AAV-based delivery of RNAi targeting Ataxin-2 improves survival, strength, and pathology in mouse models of rapidly and slowly progressive sporadic ALSDefne A. Amado, Beverly L. Davidson|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 6